Jones Financial Companies
CRBU icon

Jones Financial Companies’s Caribou Biosciences CRBU Stock Holding History

Jones Financial Companies’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$336 Hold
200
– – ﹤0.01% 4810
2026
Q1 		$356 Hold
200
– – ﹤0.01% 4544
2025
Q4 		$318 Hold
200
– – ﹤0.01% 4224
2025
Q3 		$426 Hold
200
– – ﹤0.01% 4053
2025
Q2 		$252 Hold
200
– – ﹤0.01% 3888
2025
Q1 		$188 Hold
200
– – ﹤0.01% 3596
2024
Q4 		$318 Buy
+200
New +$402 ﹤0.01% 3276

Other funds holding CRBU

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Jones Financial Companies's CRBU Position: Q2 2026 in Review

Jones Financial Companies held its Caribou Biosciences (CRBU) position steady in Q2 2026 at 200 shares worth $336. The position accounts for ﹤0.01% of the portfolio, ranked #4810.

Jones Financial Companies first reported a position in CRBU in Q4 2024 and has held it in 7 quarters since. The position peaked at $426 in Q3 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q2 2026.

  • Jones Financial Companies held 200 shares of Caribou Biosciences worth $336 as of Q2 2026.
  • Jones Financial Companies left its Caribou Biosciences share count unchanged in Q2 2026.
  • Caribou Biosciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4810 holding.
  • Jones Financial Companies first reported a position in Caribou Biosciences in Q4 2024 and has held it in 7 quarters since.
  • Jones Financial Companies's Caribou Biosciences position peaked at $426 in Q3 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.